Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-07-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1253604/full |
| _version_ | 1797778060990218240 |
|---|---|
| author | Nick Giannoukakis Kyle S. McCommis |
| author_facet | Nick Giannoukakis Kyle S. McCommis |
| author_sort | Nick Giannoukakis |
| collection | DOAJ |
| first_indexed | 2024-03-12T23:11:54Z |
| format | Article |
| id | doaj.art-c8f409329f154534ac11b49f44bf1dfb |
| institution | Directory Open Access Journal |
| issn | 1664-2392 |
| language | English |
| last_indexed | 2024-03-12T23:11:54Z |
| publishDate | 2023-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj.art-c8f409329f154534ac11b49f44bf1dfb2023-07-18T01:00:47ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-07-011410.3389/fendo.2023.12536041253604Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approachesNick Giannoukakis0Kyle S. McCommis1Department of Immunology, University of Pittsburgh, Pittsburgh, PA, United StatesDepartment of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United Stateshttps://www.frontiersin.org/articles/10.3389/fendo.2023.1253604/fullNAFLDNASHdiabetesT2DT1Dpharmacotherapeutics |
| spellingShingle | Nick Giannoukakis Kyle S. McCommis Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches Frontiers in Endocrinology NAFLD NASH diabetes T2D T1D pharmacotherapeutics |
| title | Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches |
| title_full | Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches |
| title_fullStr | Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches |
| title_full_unstemmed | Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches |
| title_short | Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches |
| title_sort | editorial diabetes and non alcoholic fatty liver disease points of physiological and mechanistic intersection and current co therapeutic approaches |
| topic | NAFLD NASH diabetes T2D T1D pharmacotherapeutics |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2023.1253604/full |
| work_keys_str_mv | AT nickgiannoukakis editorialdiabetesandnonalcoholicfattyliverdiseasepointsofphysiologicalandmechanisticintersectionandcurrentcotherapeuticapproaches AT kylesmccommis editorialdiabetesandnonalcoholicfattyliverdiseasepointsofphysiologicalandmechanisticintersectionandcurrentcotherapeuticapproaches |